[Use of antibiotics for asthma and COPD exacerbation].
Most patients with asthma do not receive antibiotics when they experience an exacerbation. In contrast, most patients with COPD exacerbations do indeed receive antibiotics. However, studies have shown that while some subgroups of patients with asthma or COPD may benefit from antibiotics, others do not. In this era of antibiotic stewardship, it is of crucial importance to use objective criteria when deciding whether or not to give antibiotics. Biomarkers, such as procalcitonin, could be helpful when making this decision. There is a clear need for well-designed and high-quality studies with enough power to evaluate the usage of these kinds of biomarkers.